Skip to main content

Your search for “Sanford Stem Cell Clinical Center” returned 99 results

Novel Drug Targeting Leukemia Cells Enters Clinical Trial

September 16, 2014

Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

December 1, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.

Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results

June 1, 2018

Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.

Clinical Trial Evaluates Safety of Stem Cell Transplantation in Spine

August 11, 2014

Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.

Latest ‘Inside Innovation’ Examines Stem Cells’ Role in Causing (and Fighting) Cancer

January 12, 2017

…Jamieson speaking on “Detection and Therapeutic Targeting of Cancer Stem Cell Evolution.” The free and public presentation will be held 4-6 p.m. on Tuesday, Jan. 17, in Roth Auditorium at the Sanford Consortium for Regenerative Medicine, 2880 Torrey Pines Scenic Drive. A networking reception will follow.

Stem Cell-Derived Therapy Shows Promise Against Treatment-Resistant Liver Cancer

July 9, 2024

Discover research from UC San Diego showing how stem cell-derived therapy, targeting treatment-resistant liver cancer through genetically modified NK cells, offers promising new avenues for immunotherapy.

UC San Diego Scientist Named Pew-Stewart Scholar for Cancer Research

June 18, 2024

Shiri Gur-Cohen, PhD — a stem cell biologist with the University of California San Diego Moores Cancer Center and Sanford Stem Cell Institute — has been named a 2024 Pew-Stewart Scholar for Cancer Research.

UC San Diego Sends Blood Stem Cells to Space

December 21, 2021

Researchers at the University of California San Diego launched blood stem cells into space aboard a SpaceX Falcon 9 rocket to study stress-induced aging and how stem cells and their progeny transform into pre-cancer and cancer stem cells associated with leukemia and other blood cancers.

State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial

August 24, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.

Body’s Own Gene Editing System Generates Leukemia Stem Cells

June 9, 2016

Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors. Researchers at University of California San Diego School of Medicine have now unraveled how pre-leukemic…

Category navigation with Social links